Literature DB >> 24377893

[Retrospective analysis on the clinical features and management of acute and subacute right ventricular perforation by pacemaker lead].

Yan Dai1, Ke-ping Chen2, Wei Hua1, Jie-lin Pu1, Xiao-qing Ren1, Shu Zhang1.   

Abstract

OBJECTIVE: To describe the clinical characteristics and management of the acute and subacute cardiac perforation by pacing leads.
METHODS: We retrospectively analyzed clinical data of patients with acute and subacute right ventricular perforation by pacemaker lead occurred in our hospital between 2006 and 2011.
RESULTS: Seven cases of confirmed acute and subacute right ventricular perforation by pacemaker lead were enrolled. The perforation rate was 0.15%, 2 cases of perforation occurred during the procedure. The main manifestation was low blood pressure and pericardial effusion. These two patients with cardiac tamponade underwent urgent percutaneous pericardiocentesis and patients recovered without complication. The remaining 5 cases of perforation occurred within 4-16 days after the pacemaker implantation. The main symptoms were diaphragm stimulation and chest pain. Signs of leads dysfunction were observed in all 5 patients. The diagnosis of cardiac perforation was confirmed by chest X-ray, echocardiography, or computed tomography. In all these 5 patients, the leads were removed by simple traction under fluoroscopic guidance with surgical backup support, no complication was observed.
CONCLUSION: Acute and subacute right ventricular perforation is a rare but serious complication of pacemaker implantation. In most patients, the leads can be safely removed under fluoroscopic guidance with surgical backup support and close monitoring.

Entities:  

Mesh:

Year:  2013        PMID: 24377893

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN: 0253-3758


  1 in total

1.  Chest pain following permanent pacemaker insertion… a case of pneumopericardium due to atrial lead perforation.

Authors:  Suleman Aktaa; Kavi Fatania; Claire Gains; Hazel White
Journal:  BMJ Case Rep       Date:  2018-10-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.